Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$14.1M
14M shares
52-week range
$0.86 – $2.67
9% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Borrow rate
53.04%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $6.6M | $2.0M | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $50.0K | $4.0M | $6.0M | $8.8M | $12.4M | $15.2M | $12.5M | $0 |
| Gross profit | −$50.0K | $2.6M | −$4.0M | −$8.8M | −$12.4M | −$15.2M | −$12.5M | $0 |
| Gross margin | — | 39.0% | -199.6% | — | — | — | — | — |
| R&D | $58.6M | $4.0M | $6.0M | $8.8M | $12.4M | $15.2M | $12.5M | $5.1M |
| Operating income | −$62.9M | −$48.4M | −$9.6M | −$14.2M | −$38.8M | −$18.6M | −$17.9M | −$9.0M |
| EBITDA | −$62.5M | −$2.2M | −$9.4M | −$14.0M | −$18.0M | −$21.0M | −$17.4M | −$8.5M |
| Net income | −$49.0M | −$48.2M | −$9.6M | −$14.2M | −$38.8M | −$18.0M | −$17.5M | −$8.8M |
| Net margin | — | -733.8% | -479.0% | — | — | — | — | — |
| EPS (diluted) | -21.01 | -15.78 | -2.01 | -1.85 | -4.77 | -0.00 | -1.72 | -0.78 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $0 | $-0.69 | $-0.75–$-0.61 | 2 |
| 2027 | $0 | $-0.64 | $-0.64–$-0.64 | 1 |
| 2028 | $0 | $-0.70 | $-0.70–$-0.70 | 1 |
Forward consensus · source: Financial Modeling Prep
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
www.cocrystalpharma.comNo one on the platform currently holds COCP.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 123,928 | $125.2K |
| Execution date | Ratio |
|---|---|
| 2022-10-11 | 1-for-12reverse |
| 2018-01-24 | 1-for-30reverse |
| 2011-03-15 | 10-for-1 |
No one on the platform has traded COCP yet.
| $3M |
| — |
| EVGNEvogene Ltd. | $0.39 | -2.31% | $3M | — |
| IMNNImunon, Inc. | $1.79 | +4.07% | $5M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$COCP After the first move to $25 + on the data coming “This was obvious.” “I don’t know how people missed this.” “The setup was so clean.” 4 years in the making in a blink
View on StockTwits ↗$COCP This fucking thing can’t even hold a buck let alone 50 dipshit Momo.
View on StockTwits ↗$COCP Hey does anyone know where Momo is?. June almost up… 50 dollars price target needs hit. Thanks for your attention.
View on StockTwits ↗$COCP They will start ringing the register soon. More bills with new CEO. Meanwhile Martin and Sam still on the payroll. Produce something guys, just anything besides bills. Thanks
View on StockTwits ↗$COCP I only have 10k shares but this could make us rich if they can pull this off!
View on StockTwits ↗$COCP July 17 2020 player bulmar LMFAO😂 let's go baby! jai wei 🤡
View on StockTwits ↗$COCP time to buy this desperate seller final shares
View on StockTwits ↗$COCP Let's go baby! you go girl Jai Wei your such a bad ass tiny winny player LMfaooo largest position in 2020 after chasing a covid stock and never selling LMFAO🤣
View on StockTwits ↗$COCP $25 real soon how bouts that new antiviral CEO
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.